Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-Ro/SS-A and anti-La/SS-B antibody levels

Modern Rheumatology

Volumn 14, Issue 2, 2004, Pages 117-122

  Shahin, Amira A ^a,b   Shahin, Hesham A ^a   Hamid, Magdy A ^a   Amin, Mona A ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Anti cardiolipin antibodies (aCL); Anti La SS B antibodies; Anti Ro SS A antibodies; Echocardiography; Pulmonary hypertension; Systemic lupus erythematosus (SLE); Valvular involvement

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; LA ANTIBODY; RO ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE FILLING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

EID: 20444396222     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0277-6     Document Type: Article

References (35)

1. Bijl M, Brouwer J, Kallenberg GG. Cardiac abnormalities in SLE: pancarditis. Lupus 2000;9:236-40
2. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus by prospective analysis. Am Heart J 1985;110:1257-65
3. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41
4. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-30
5. Nihoyannopoulos P, Gomez PM, Joshi G, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: Association with raised anticardiolipin antibodies. Circulation 1990;82:369-75
6. Hojnik M, Goerge J, Ziporin L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in antiphospholipid syndrome. Circulation 1996;93:1579-87
7. Giunta A, Picillo U, Maione S, Migliaresi S, Valentini G, Arnese M, et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunological investigation. Acta Cardiol 1993;48:183-97
8. Metz D, Jolly D, Graciet-Richard J, Nazeyrollas P, Chabert JP, Maillier B, et al. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: A matched echocardiographic study. Cardiology 1994;85: 129-36
9. Gentile R, Lagana B, Tubani L, Casato M, Ferri GM, Fedele F. Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: Correlation with levels of antiphospholipid antibodies. Ital Heart J 2000;1:487-92
10. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125: 1123-9
11. Alves LJ, Hydalgo L, Rolim LF, Campagnone GZ, Aidar MT, Novaes GS, et al. Clinical and laboratory diagnosis of heart disease in systemic lupus erythematosus. Cardiology 1997;68:79-83
12. Rantapaa-Dahlqvist S, Neumann-Andersen G, Backman C, Dahlen G, Stegmayr B. Echocardiographic findings, lipids and lipoprotein (a) in patients with systemic lupus erythematosus. Clin Rheumatol 1997;16:140-8
13. Gabrielli F, Alcini E, Prima MA, Lucifero A, Masala C. Cardiac involvement in connective tissue diseases and primary anti-phospholipid syndrome: Echocardiographic assessment and correlation with antiphospholipid antibodies. Acta Cardiol 1996;51:425-39
14. Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: Lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117-26
15. Lagana B. Cardiac abnormalities in systemic lupus erythematosus and their association with antiphospholipid antibodies. Recenti Prog Med 1993;84:662-72
16. Silverman E, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal heart block and neonatal lupus erythematosus. J Rheumatol 1991;18:120-4
17. Logr D, Kveder T, Rozman B, Dobovisek J. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 1990;49:627-9
18. Ristic AD, Maisch B. Cardiac rhythm and conduction disturbances: What is the role of autoimmune mechanisms? Herz 2000;25:181-8
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7
20. Abascal VM, Wilkins GT, Choong CY, Block PC, Palacios IF, Weyman AE. Mitral regurgitation after percutaneous balloon mitral valvuloplasty in adults: Evaluation by pulsed Doppler echocardiography. J Am Coll Cardiol 1988;257-63
21. WHO Cardiovascular Disease Unit and Principal Investigators. WHO programme for the prevention of rheumatic fever and rheumatic heart disease in 16 developing countries: Report from phase 1 (1986-1990). Bull WHO 1992;70:213-8
22. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 1975;58:243-64
23. Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus: A review. J Thorac Cardiovasc Surg 1983;85:718-26
24. Straaton K, Winn Chatam W, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988;85:645-50
25. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del Castillo H, Soler-Soler J. Prevalence, morphologic types, and evaluation of cardiac valvular diseases in systemic lupus erythematosus. N Engl J Med 1988;319:817-23
26. Cervera R, Khamashta MA, Font J. High prevalence of significant heart valve lesions in patients with the primary antiphospholipid syndrome. Lupus 1991;1:43-7
27. Martin-Villa JM, Martinez-Lazo J, Morino-Pelayo MA, Castro-Panete MJ, Martinez-Quiles N, Alvarez M, et al. Differential contribution of HLA-DR, DQ and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: Role of TAP2*01 alleles in Ro antibody production. Ann Rheum Dis 1998;57:214-8
28. Buyon JP. Neonatal lupus: Bedside to bench and back. Scand J Rheumatol 1996;25:271-6
29. Silverman ED, Buyon J, Laxer RM, Hamilton R, Bini P, Chu JL, et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995;100:499-505
30. Von Muhler CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58
31. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002;40:796-802
32. Buyon JP. Neonatal lupus syndromes. Curr Opin Rheumatol 1994;6:523-9
33. Oshiro AC, Derbes SJ, Stopa AR, Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis 1997; 56:272-4
34. Tsuji M, Nakatani T, Nojiri T, Nishio H, Shima H, Hiroi Y, et al. A case of Sjögren's syndrome with valvular diseases. Jpn Heart J 1986;27:137-43
35. Espinola Zavaleta N, Morales Blanhir J, de Witt Garcia M, Romero Cardenas A, Vargas Barron J. Echocardiographic findings in primary Sjögren syndrome. Arch Inst Cardiol Mex 1997;67:114-25